Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Literature
1.
Denys A, Prior J, Bize P (2011) Portal vein embolization: what do we know? Cardiovasc Intervent Radiol (in press)
2.
Madoff DC, Abdalla EK, Gupta S et al (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16:215–225PubMedCrossRef
3.
de Baere T, Teriitehau C, Deschamps F et al (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17:2081–2089PubMedCrossRef
4.
Kishi Y, Madoff DC, Abdalla EK et al (2008) Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery 144:744–751PubMedCrossRef
5.
Nagino M, Kamiya J, Kanai M et al (2000) Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 127:155–160PubMedCrossRef
6.
de Baere T, Denys A, Paradis V (2009) Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol 19:1435–1442PubMedCrossRef
7.
Saad NEA, Menias CO, Pilgram TK, Chapman WC, Strasberg SM, Picus D (2008) Portal vein embolization for future liver remnant hypertrophy prior to trisegmentectomy: choice of embolic agent. J Vasc Interv Radiol 19:S75–S76CrossRef
8.
Siegelbaum RH, Lehrman ED, Oyfe I et al (2010) Comparison of left hepatic hypertrophy after portal vein embolization with n-BCA or Tris-Acryl microspheres. J Vasc Interv Radiol 21:125CrossRef
9.
Madoff DC, Abdalla EK, Vauthey JN (2005) Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 16:779–790PubMedCrossRef
Metadata
Title
Re: Portal Vein Embolization: What Do We Know?
Authors
David C. Madoff
Jean-Nicolas Vauthey
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 3/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-012-0407-z

Other articles of this Issue 3/2013

CardioVascular and Interventional Radiology 3/2013 Go to the issue

Letter to the Editor

Criteria to Choose between Distal or Proximal Venous Port Device Insertion in HNC Patients

Clinical Investigation

Saline as the Sole Contrast Agent for Successful MRI-guided Epidural Injections

Case Report

Endovascular Treatment of Totally Occluded Superior Mesenteric Artery by Retrograde Crossing via the Villemin Arcade

Letter to the Editor

Letter Reply Re: “Endoscopy-Guided Empiric Arterial Embolization for Angiographically Negative Upper Gastrointestinal Bleeding: Use it Without Fear!”

Case Report

Percutaneous Cryotherapy of Vascular Malformation: Initial Experience

Technical Note

Temporary Arterial Balloon Occlusion as an Adjunct to Yttrium-90 Radioembolization